Approval · Notice of Compliance 3094 · 1998
NIMOTOP: Notice of Compliance 3094
Issued May 6, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3094
- Date
- May 6, 1998
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revision of product monograph - clinical trials section
- Therapeutic class
- Calcium channel blocking agent; adjunct in management of subarachnoid hemmorrage
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NIMOTOP | Not yet assigned | — |
Medicinal ingredients
- NIMODIPINE 0.2 MG per ML